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VAN DER HEIJDEN OPINION ON AN ACTIVATED LACTOPEROXIDASE SYSTEM 
EXPRESSED ON 19 JUNE 1992 
1. Terms of reference 
The Committee was asked to evaluate the safety in use of an activated lactoperoxidase system for 
the control of micro-organisms in milk intended for cheese production. 
2. Background 
The activated lactoperoxidase system concerned relies for its anti-microbial action on the interaction 
between three components: 
- bovine lactoperoxidase 
sodium thiocyanate 
and 
- hydrogen peroxide. 
The hydrogen peroxide may be generated either by a secondary enzymatic system consisting of glucose 
oxidase and its substrate glucose, or by lactic acid bacteria such as those of the lactobacillus group. 
3. Discussion and conclusions 
The Committee noted that: 
a) the system proposed is intended to combat the microbial contamination of milk used in the 
manufacture of different types of cheeses. The committee insists that, if such a system were to be 
employed, it should not have the effect of encouraging practices which would lead to a failure to 
use all hygiene measures aimed at improving the microbiological quality of milk intended for the 
manufacture of cheese and of the conditions under which the manufacture takes place; 
b) the level of each component of the complex system proposed varied according to the conditions of 
assay. It does not seem to the Committee that the practical circumstances of use in different 
situations are as yet well defined, nor that the microbiological efficacy of the system (in 
particular against Listeria monocytogenes, Staphylococcus aureus, Salmonella typhimurium, 
Escherichia coli etc.) has been rigorously demonstrated; 
c) the dossier submitted does not follow the guidelines of the Committee concerning the presentation 
of data on food enzymes (Twenty-seventh Series of Reports of the Scientific Committee for Food, 
1992 EUR14181) in relation to the two enzymes constituting the system: lactoperoxidase and 
glucose oxidase. 
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The Committee is unable to reach a judgement on the dossier without further information on the 
following points: 
- full dossiers on lactoperoxidase and glucose oxidase presented according to the committee's 
guidelines; 
- information on the precise composition of the system under the different conditions of use for 
which approval is sought and evidence of the system's microbiological efficacy; 
- for the different conditions under which the system would be used, information on the kinetics of 
the formation of oxythiocyanate ion and the disappearance of thiocyanate ion, and the kinetics 
of the formation, disappearance and/or accumulation of hydrogen peroxide 
(the Committee noted that for identical proportions of each of the constituents of the system, the 
accumulation of hydrogen peroxide appeared to depend on the concentration of the system in the 
solution employed). 
The Committee considers these data to be necessary to demonstrate that the system can be used in a 
well controlled manner. 
The committee is unable to come to any judgement on the toxicological data supplied in the absence of 
the detailed information requested above. 
In effect, the Committee must have at its disposal data concerning the potential toxicity of the 
system functioning under rigorously identical stoichiometric conditions to those which would occur in 
practice and which would therefore produce intermediate and end products in the same quantities and 
proportions. 
Finally the Committee wishes to have at its disposal a detailed account of the results of the 
utilisation of the activated lactoperoxidase system in milk, in the countries where the system has 
already been employed. 
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1. Terms of reference 
The Committee was asked to re-evaluate in the light of the most recent information on technology 
and toxicology, the modified celluloses permitted by the Council Directive relating to emulsifiers, 
stabilisers, thickeners and gelling agents for use in foodstuffs (74/329/EEC, as amended). 
2. Background 
Five modified celluloses are permitted in the EEC under the Directive on Emulsifiers, Stabilizers and 
Thickening Agents (74/329/EEC). These comprise methylcellulose (Ε 461), hydroxypropylcellulose (Ε 
463), hydroxypropylmethylcellulose (E 464), ethylmethylcellulose (E 465) and sodiumcarboxy-
methylcellulose (E 466). Specifications for these five substances have been published in the Directive 
78/663/EEC. Of these compounds only E 466 has been evaluated by the SCF in the 7th Series of 
Reports in 1978, when a group ADI of 25 mg/kg b.w. (previously established by JECFA in 1973) was 
endorsed together with the rider, that specifying a limit to the molecular weight was considered 
unnecessary. The Committee had not been asked at that time to evaluate the other permitted 
modified celluloses. 
3. Discussion 
JECFA has evaluated seven modified celluloses, the five substances in the EEC Directive as well as 
ethylcellulose and ethylhydroxyethylcellulose. That committee initially established a group ADI 
of 25 mg/kg b.w., based on the traditional procedure of using the highest NEL obtainable in lifespan 
studies without causing any nutritional effects and a safety factor of 100. It was realised subsequently 
that food additives which are poorly, if at all, absorbed and practically non-toxic when tested 
extensively in animals, do not produce adverse effects in feeding studies, even at the maximum levels 
of dietary incorporation consistent with mild adverse nutrition of the test animals. The observed 
gastro-intestinal effects were clearly produced by the physical effects of the bulk and the 
hydrophilic properties of the ingested materials. It was therefore illogical to persist with the 
traditional evaluation procedures for these substances. 
If, in addition, information on the chemical structure, absorption, tissue distribution, excretion, 
metabolism and human exposure together with appropriate clinical observations suggested, that no 
true toxic effects could be expected even after high intakes, then a numerical limitation of the ADI 
becomes unnecessary. JECFA therefore allocated, on the basis of these arguments, in 1990 a group ADI 
"not specified", as had been done with other bulking food additives, to the seven modified celluloses 
evaluated in its 35th session. The committee made, however, a general comment on the need to 
consider the possible laxative effect of an excessive total dietary consumption of all bulking agents, 
particularly in view of the additivity of this effect. It therefore suggested that some controls to limit 
consumption should be introduced. 
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A review of the available data, summarized in the attached table, on the five modified celluloses 
listed in the Directive 74/329/EEC, which covered chemical structure, biochemical behaviour, 
toxicological properties and clinical observations in man, demonstrates that modified celluloses are 
practically non-absorbed by mice, rats rabbits and man, are of low toxicity and do not possess 
carcinogenic properties. Only E 461 and E 466 have been tested for mutagenic properties, both 
substances yielding no evidence of any mutagenic potential. The three modified celluloses E 461, E 463 
and E 466 have been shown to cause no embryotoxic or teratogenic effects. The human data, covering 
ingestion of amounts up to 30 g/day/person, suggest the usual effects of undigestible fibre on the bulk, 
the physical consistency, and the frequency of faeces without however causing clinically significant 
diarrhoea at this level of ingestion. Information available to the Committee indicates that average 
daily intakes from present uses are well within this range. 
4. Conclusions 
Consistent with its evaluation of bulking agents with similar biological properties, the Committee 
allocated an ADI "not specified" to the five modified celluloses listed in Directive 74/329/EEC. 
This evaluation relates to present food additive uses only, where levels of addition are commonly in 
the range 0.2 - 3.0 % of the foodstuff. Provided uses remain as at present and levels of addition are 
within the limits of those necessary for strictly technological purposes, true clinical laxative effects 
are unlikely to occur. However, the contribution of other dietary constituents with potential laxative 
effects to the overall dietary load of substances with this biological property should be kept under 
review. 
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OPINION ON ENZYMATICALLY HYDROLYSED CARBOXYMETHYLCELLULOSE 
EXPRESSED ON 11 DECEMBER 1992 
Subsequent to the request to re-evaluate the five modified celluloses permitted by Council directive 
74/329/EEC, the Committee was asked to evaluate the safety in use of an enzymatically hydrolysed 
form of carboxymethylcellulose. The enzyme concerned is a cellulase derived from Trichoderma 
longibrachiatum (T. reesei) and its use results in a significant reduction of the average molecular 
weight of the carboxymethylcellulose and hence in changes in its technological properties. The 
Committee was provided with a 90-day feeding study on the material carried out in rats and a 
radiolabel metabolic balance study comparing hydrolysed carboxymethylcellulose with conventional 
carboxymethylcellulose, also in rats. 
The Committee concluded that the enzymatically modified carboxymethylcellulose in question is 
acceptable and included it in the group ADI "not specified" previously allocated to the five currently 
permitted modified celluloses. The group ADI is subject to the limitation of the celluloses concerned to 
the levels of addition strictly necessary for technological purposes and is subject to the need to keep 
under review the overall dietary load of substances with a potential for laxation. 
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DRINK 
EXPRESSED ON 19 JUNE 1992 
1. Terms of reference 
The Committee was asked to evaluate the potential risk to health presented by lead in food and 
drink. This evaluation took into account a report prepared at the request of the Commission of the 
European Communities by the National Food Agency of Denmark (Levnedsmiddelstyrelsen). It 
addressed essentially two aspects: 
2. Discussion 
2.1 Toxicity of lead 
A large number of data concerning the toxicity of low doses of lead in man have become available in 
the course of the last 10 to 15 years. The key questions today seem to be those concerning the effects of 
lead on the central nervous system of the foetus and of the young child, and its action on arterial blood 
pressure in the adult. These effects are apparent with circulating blood-lead levels of the order of 
around 15 μg/dl. 
Whilst in 1990 the Committee endorsed the provisional tolerable weekly intake (PTWI) of 25 μg of 
lead per kg bodyweight for children proposed by the WHO in 1986, it considers it must now undertake 
a comprehensive re-examination of the toxicity of lead in order to arrive at a new evaluation of the 
PTWI for children and for adults in the light of the most recent data. 
The Committee wishes to pursue this work in concertation with other organisations who have also 
undertaken the re-evaluation of the toxicology of lead (the WHO International Programme on 
Chemical Safety; the United States Food and Drug Administration and Environmental Protection 
Agency). 
2.2 Dietary sources of lead 
The three major dietary sources of lead, responsible for at least 70% of exposure, are: 
fruits and vegetables; 
- cereals; 
drinks. 
Their respective contributions, variable with country according to dietary habits, are essentially 
identical. Amongst drinks, wine is a non-negligible source of lead. 
Reports of the Scientific Committee for Food (Thirty-second series) 19 JUNE 1992 THE POTENTIAL RISK TO HEALTH PRESENTED BY LEAD IN FOOD AND DRINK 
Where, as for certain countries, comparative data exist, it is apparent that dietary contributions of 
lead have diminished in the course of recent years. This diminution can be attributed: 
- to the use of lead-free petrol for automobiles in the case of fruits and vegetables; 
- to a progressive reduction in the use of lead solders for cans used to conserve fruits, vegetables and 
fruit juices etc. 
3. Conclusion 
The mean level of contamination of foodstuffs does not seem to be a cause for alarm. However, the 
high values which have been observed in extreme cases must be considered as anomalies due to errors 
during production and processing which it is necessary to identify. 
Recent data obtained in the European Community on the initiative of the European Commission show 
that this is also the case for wine produced in the Community. For this reason the Committee 
encourages the Commission to undertake studies designed to establish the cause of the rare anomalies 
observed, enabling measures to be taken to eliminate progressively the production of wines with lead 
contents grossly in excess of the mean. 
Efforts should equally be made towards the elimination of lead solders in cans for food-use within the 
Community and on the surveillance of imported cans. 
The "seeking out" of anomalies could be the means of a rapid improvement in the situation. Longer 
term action should follow with the objective of further lowering the mean lead level of foodstuffs in 
general. 
The Committee wishes to undertake a re-examination of the toxicity of lead in concertation with 
other organisations which are presently considering the issue. 
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EXPRESSED ON 9 OCTOBER 1992 
1. Terms of reference 
The Committee was asked to evaluate the safety use of Sucrose Acetate Isobutyrate (SAIB) as a 
stabilizer in soft drinks. 
2. Background 
SAIB is a mixed acetyl and isobutyryl ester of sucrose. 
CH2OR 
OH CH2OR o H R = -COCH3-COCH(CH3)2 
OR 
OR^ 
CH2OR 
Η OR OR Η 
Use levels may vary from 50 - 400 mg/1, being most commonly 300 mg/1, of beverage. 
3. Evaluation and conclusion 
Metabolic studies in rats, dogs and man have shown, that the rat and man eliminate about 50% of 
SAIB as expired CO2, while the dog eliminates only 25% by this route. Rat and man excrete about 20 -
30 % of the administered dose as metabolites in their urine and 10 - 20 % as intact SAIB and 
metabolites in the faeces. The dog, on the other hand, excretes about 7% metabolites in the urine and 
about 50% of SAIB and metabolites in the faeces. Dogs appear to excrete highly acetylated sucrose in 
the urine while the rat and man excrete less highly acetylated partial sucrose esters. Although rats, 
dogs, monkeys and man absorb SAIB easily, the dog, in contrast to rat, monkey and man, appears to be 
unable to degrade the highly acetylated sucrose. 
With regard to hepatobiliary function the dog appears to be a particularly sensitive species. Short 
and long-term studies in the mouse and rat as well as a one year study in monkeys produced no adverse 
hepatic effects and showed no evidence of interference with hepatobiliary function. Studies in 
human volunteers similarly produced no indications of any adverse effects on hepatobiliary function. 
In the light of the above studies taken in conjunction with the reassuring evidence from the study in a 
primate species, it would not be unreasonable to consider the hepatic effects, noted in the dog, as 
having little relevance to the evaluation of the safety of SAIB in man. The chronic studies in the rat, 
the species relevant for evaluating the safety in man, can therefore be used for establishing a no-
adverse effect level and consequently of an ADI. 
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This no-adverse effect level is based on the results of long-term studies which have shown that at the 
highest dose levels used, there is some evidence of an effect on bodyweight and food consumption in 
both sexes. At the lg/kg b.w. dose level, no consistent adverse effects were noted. 
Using a safety factor of 100 in view of the adequacy of the data base now available, the Committee 
allocated an acceptable daily intake (ADI) of 10 mg/kg b.w. calculated as SAIB. 
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RESINS 
EXPRESSED ON 11 DECEMBER 1992 
1. Terms of reference 
To advise on the acceptability of wines treated with certain ion-exchange resins (IXR) from the point 
of view of safety to health or the consumer. 
2. Background 
The use of IXRs in oenological practice has been under consideration since 1945 and is being practised 
particularly in the USA and Australia. The primary objective of this process is the prevention of 
further precipitation of K-bitartrate in wine, bottled after the usual bulk cold storage, by the 
reduction in the pH of the wine or grape juice. The technology involves the treatment of a portion, 
varying from an average 5 % to a maximum of 20% of the total wine stored before bottling, by a by-
pass operation with continuous refeeding into the bulk wine. The actual portion eventually passed 
through the IXR column depends on the analysis of the wine before treatment, particularly for K+, 
pH and tartrate. It is known that the K+ concentration in the grape berry is the most important 
indicator for the pH, the titratable acidity and the K-bitartrate content of grape juice and wine. In a 
good quality product there should be no excess of K+, and thus a lower pH and smaller K-bitartrate 
content. 
Cold storage for a considerable period and the addition of tartaric acid have been, in the European 
Community, the traditional means of stabilising stored wine, largely preventing sediment formation 
after bottling. In the USA there is an absolute consumer requirement for bottled wine to be perfectly 
clear without any evidence of haze or deposit. The US wineries claim that, because of the often 
extreme variations in temperature encountered across the country during transport and storage on 
business premises, the traditional methods will not guarantee a stable and absolutely clear bottled 
wine when marketed. They are therefore dependent on using essentially cationic LXRs to exchange the 
K+ for H+ in a portion of the stored bulk wine, thereby avoiding the unstable supersaturation with K-
bitartrate. In rare circumstances, for special regional products already having initially a very low 
pH, K+ may be exchanged for Na+ with a maximum limit of 200 mg Na/1 for nutritional reasons. It 
should also be borne in mind, that it is current practice in the European Community to treat portions, 
between 10%-40%, of clarified grape juice with IXRs and then to blend these back with the untreated 
portion. 
The preferred treatment is by cationic IXRs but anionic IXRs are also used, though far less frequently, 
in the production of dessert wines. Anionic IXRs are not used for general treatment because even small 
changes in the anion content are likely to affect the taste and quality characteristics of the wine to a 
recognisable extent. Mixed cationic and anionic IXRs are never used. Any treatment with cationic and 
anionic or non-ionic IXRs is always carried out consecutively in separate IXR towers. 
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3. Discussion 
3.1 Nature of IXRS 
In the USA the use of IXRs for treating potable water and in food processing is generally permitted 
under FDA Regulations 21 CFR 173.25. These regulations list 19 different IXRs (see annex), setting out 
their approximate chemical type, physical form, functions and conditions of use. They also lay down 
strict limits for purity and global but not specific migration of IXR constituents under prescribed 
conditions of testing. Of these 19 listed IXRs some 4 (al2, al3, al6, al8) are excluded from use in the 
treatment of wine. Of the remaining 15 IXRs only 5 (al, a3, a4, a5, a7) are claimed to be in actual use 
by wineries. Of these the IXR al is the most widely employed cationic IXR in the production of table 
wines. The IXRs a4 and a7 (anionic) are used far less frequently and then only in the production of 
dessert wines. No information on the use of IXRs a3 and a5 was available. The BATF (= US Bureau of 
Alcohol, Tobacco and Firearms) is, however, anxious to maintain the other 10 IXRs as possible 
candidates for reasons of flexibility. Neither the BATF nor the US wine industry are able to state at 
present, which of the 10 potential candidate IXRs were still being manufactured today and were 
specifically suitable for the treatment of wine. 
The monomers permitted for producing the resin matrix include styrene, divinylbenzene, 
phenolformaldehyde, methacrylic acid and methacrylate, epichlorhydrin and acrylonitrile. All of 
these are also presently permitted in the Community for the production of packaging and materials in 
contact with food. The permitted additives include NH3, H2O2, acetone, methylchloride, 
chlormethylating agents, trimethylamine, dimethylamine, diethylenetriamine, dimethyleth-
anolamine, triethylenetetramine, and tetraethylenepentamine. Almost all of these are also in use in 
the Community for the production of plastic food packaging. The overall global extraction limit set 
the FDA is 1 mg/1 organic extractives in either distilled water, 15% aqueous alcohol or 5% acetic 
acid. In the H202-modified resins up to 7 ppm nitrogenous extractives are permitted. The Australian 
wine industry apparently uses the same IXRs that are permitted in the USA. 
The Council of Europe (CoE) has published a Resolution AP(89)2 which aims at regulating the use of 
IXRs in general food processing but excludes cellulosic and inorganic matrix IXRs. One appendix lists 
the acceptable monomers and other starting substances, chemical modifiers, and polymerisation aids. 
Another appendix lists the provisionally acceptable substances falling into the same three 
categories. The limits for migration of the IXR constituents and the simulants to be used in the 
determination of the migration characteristics are identical with those set by the FDA in 21 CFR 
173.25. In addition, a large number of specific migration limits for many of the permitted components 
of the IXRs is laid down, the "not detectable" limitation being set at 0.1 mg/1 extradant. The CoE list 
does not indicate which substances are to be permitted specifically for the treatment of alcoholic 
beverages and wine. In this respect the CoE lists are less useful for assessing the safety aspects of the 
IXRs used in the treatment of wine. 
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3.2 Safety to health considerations 
The FDA Regulations 21 CFR 173.25 permit the use of 19 IXRs for treating potable water and in food 
processing. Of these 5 IXRs are used in practice for the treatment of wine since the early 1960s. The 
remainder is used for the treatment of potable water and in the processing of food. 
The basis for FDA approval was 
a ) some IXRs were already in use before the 1958 Food and Drug Act; 
b) the monomers and additives used in these IXRs have been approved already for years as 
components of food contact materials without apparently having caused any health problems; 
c) these IXRs have been tested for compliance with the migration limits set out in 21 CFR 173.25 and 
the data, including some studies with radio labelled materials, are held by the FDA; 
d) none of the monomers are known carcinogens and only a few may be regarded as probable 
carcinogens; 
e) exposure of the consumer from migration into food was considered infinitesimal taking into account 
the ratio between the very large mass of food or liquid processed and the weight of IXR used in 
the treatment columns. 
Migration from the aforementioned 15 IXRs is limited in the FDA Regulations to 1 ppm of organic 
extractives obtained with each of the solvents, distilled water, 15% ethyl alcohol and 5% aqueous 
acetic acid, when prepared ready for use with food. Because of the chemical nature of the IXRs 
certain modifications of the procedure for determining migration are specified in the Regulations. It is 
thus clear that the residues from migration are strictly limited particularly when IXRs are used for 
the treatment of wine. 
The cationic IXRs, once loaded into an exchange tower, remain in constant use from 10-20 years. About 
2% of IXR per year requires replacement with fresh resin because of losses as a result of purely 
physical break-up of the resin particles during the regeneration, washing and nitrogen blowing cycles 
required at regular intervals to maintain the activity of the column. The resulting fine powder of 
broken up IXR is removed every time the column is used after regeneration and before a new treatment 
cycle. Because anionic IXRs are slightly less stable, about 4% IXRs have to be replaced per year 
giving an average column life of about 10 years. 
Between 75% -100% of bottled US table wine on the market contains wine treated with IXRs. The 
quantity of wine treated in any by-pass operation varies, depending on the analysis of the bulk wine, 
between 10%-15%, as a maximum, of the total stored bulk wine before bottling. The actual quantity of 
wine passing through an exchange column is about 75-150 million gallons in 10 years for cationic IXRs 
and slightly smaller for anionic IXRs. Thus, in both cases, any migrant from the IXR would be 
enormously diluted even before it reaches the main bulk of the wine stored before bottling. 
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Taking into account the vast dilution of any migrant from the IXRs the exposure of the consumer can be 
regarded as infinitesimal, whichever of the 5 IXRs is being employed. In addition the toxicological 
information available on these IXRs suggests that the monomers are not carcinogenic and have not 
given rise to toxicological problems. 
In view of the infinitesimal actual exposure of the consumer to any migrating component from the IXRs 
a detailed knowledge of the SMLs of all monomers and additives is superfluous. Furthermore, because 
IXRs are never mixed in any given single column and these columns are used in series, there is also no 
need to consider combination effects of IXRs. It would also be inappropriate to demand general 
screening tests of IXRs with solvents other than those legally stipulated in 21 CFR 173.25, which are 
incidentally similar to those listed in the COE Regulation. 
4. Conclusion 
On the basis of the information received on the technology, on the general nature of the IXRs, and on 
the likely exposure of the consumer to any migrating constituents of these IXRs, which might 
conceivably be present in wine bottled after treatment with the IXRs al, a4 and a7, the only IXRs 
claimed to be used in the USA and in Australia, the Committee is of the opinion, that the 
consumption of imported wines treated with the aforementioned IXRs does not constitute any health 
hazard to the consumer. 
Before the Committee can consider extending the advice on acceptability to wines treated with other 
IXRs, the Committee would require, as a minimum, information similar to that furnished for the 3 
IXRs mentioned above as well as any other relevant information which might be needed for an 
appropriate risk assessment, in particular, more details on the actual quantities of wine passing 
through the exchange columns for each IXR used and their replacement frequencies. 
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List of ion-exchange resins permitted in the USA for wine treatment 
Resin code Chemical name 
a ( 1 ) Sulfonated copolymer of styrene + divinylbenzene 
a (2) Sulfonated anthracite coal 
a(3) sulfite modified crosslinked phenol-formaldehyde w/sulfonic acid groups on side 
chains 
a(4) Methacrylic acid-divinylbenzene copolymers 
a(5) Crosslinked polystyrene chloromethylated + aminated w/trimethylamine, 
dimethylamine, diethylenetriamine, or dimethylethanolamine 
a(6) Diethylentriamine, triethylenetetramine, tetraethylenepentamine crosslinked 
w / epichlorohydrin 
a(7) Crosslinked phenol-formaldehyde activated w/triethylene tetramine and/or 
tetraethylenepentamine 
a(8) Reaction resin of formaldehyde, acetone, and tetraethylenepentamine 
a(9) Completely hydrolyzed copolymers of methyl acrylate and divinylbenzene 
a(10) Completely hydrolyzed terpolymer of methyl acrylate, divinylbenzene and 
acrylonitrile 
a (11) Sulfonated terpolymers of styrene, divinylbenzene and acrylonitrile or methyl 
acrylate 
a(12) Methyl acrylate - divinylbenzene copolymer w/ > 2% divinylbenzene, aminolyzed 
w/dimethylaminopropylamine 
a(13) Methyl acrylate - divinylbenzene copolymer w/ > 3.6% divinylbenzene, aminolyzed 
w/dimethylaminopropylamine 
a(14) Epichlorohydrin crosslinked w/ammonia 
a(15) Sulfonated tetrapolymer of styrene, divinylbenzene, acrylonitrile, and 
methylacrylate from mixture of monomers w/ < 2% acrylonitrile + methyl acrylate 
a(16) Methyl acrylate - divinylbenzene - diethylene glycol divinyl ether terpolymer w/> 
3.5% divinylbenzene and < 0.6% diethylene glycol divinyl ether, aminolyzed 
w / dimethylaminopropylamine 
a(17) Styrene-divinylbenzene crosslinked copolymer, chloromethylated + aminated 
w/dimethylamine and oxidized w/hydrogen peroxide w/< 15% vinyl N,N-
dimethylbenzylamine-N-oxide and < 6.5% nitrogen 
a(18) Methyl acrylate - divinylbenzene - diethylene glycol divinyl ether terpolymer w/7% 
divinylbenzene and < 2.3% of diethylene glycol divinyl ether, aminolyzed 
w/dimethylaminopropylamine and quatemized w/methyl chloride 
a(19) Epichlorohydrin crosslinked w/ammonia and quatemized w/methyl chloride to 
contain < 18 % strong base capacity 
Reports of the Scientific Committee for Food (Thirty-second series) 15 OPINION ON CERTAIN ADDITIVES FOR USE IN INFANT FORMULAE, FOLLOW-ON 
FORMULAE AND WEANING FOODS 
EXPRESSED ON 11 DECEMBER 1992 
1. Terms of reference 
To advise on the safety of a series of additives for use in infant formulae, follow-on formulae and 
weaning foods not included in the European Commission Proposal for a Council Directive on Food 
Additives Other Than Colours and Sweeteners (1). 
2. Background 
The European Commission Proposal for a Council Directive on Food Additives Other Than Colours 
and Sweeteners (1) includes at Annex VI a list of the food additives which should be permitted in 
infant formula, in follow-on formula and in weaning foods. The Committee has given an opinion on the 
use of these technological additives in earlier reports on Infant Formulae and Follow-Up Milks 
(27/4/83) (Fourteenth Series) (2) and on Weaning Foods (27/10/89;30/3/90) (Twenty-fourth 
Series)(3). Industry has now submitted a request for the addition of a new set of additives to Annex VI 
of the Council Proposal. 
3. Discussion and conclusions 
3.1 Principles used in the evaluation 
The consideration of the safety of additives for use in infant formulae, follow-on formulae and 
weaning foods is a special case. The immaturity of the organs of absorption, metabolism or excretion 
may mean that the distribution of an additive in the body is different in the infant or young child 
than in the adult. In addition, developing organs and tissues may show greater sensitivity to the 
effects of an additive than mature organs and tissues. The Committee notes that infant formulae 
milks can constitute virtually the entire infant diet and therefore patterns of exposure to additives 
used in such formulae is very different to the normal situation of additives approved for general food 
use. 
For all these reasons the Committee considers it prudent that the number and amounts of additives 
used in foods for infants and young children should be kept to the ininimum necessary. The Committee 
confirms its long standing view that additives should not be permitted in foods specially prepared for 
infants. Rarely, exceptional technological circumstances may justify the use of an additive. In such 
cases submissions should be accompanied by a full justification, including evidence of safety, for the 
use requested. Where the requests concern additives falling into functional classes represented by 
substances approved already, the justification should explain why the existing additives are not 
sufficient for the use in question 
Reports of the Scientific Committee for Food (Thirty-second series) 17 11 DECEMBER 1992 ADDITIVES FOR USE IN INFANT & FOLLOW-ON FORMULAE AND IN WEANING FOODS 
This is especially so for additives in infant formulae. As part of the evaluation of the acceptability 
of additives in this class of foods it is necessary to have detailed information about the function of 
the additive, the minimum concentration of it required to have the desired effect, and the benefits 
arising from the use of the additive. It should also be noted that an additive with an ADI 'not 
specified' for general food use may not be acceptable for use in infant formulae or other foods specially 
prepared for infants and young children. 
3.2 Additives for use in infant formulae 
E338 Phosphoric acid 
The Committee considered phosphoric acid as an additive for general food use in its Report on a First 
Series of Food Additives of Various Technological Functions (Twenty-fifth Series, 1991)(4). The 
possible concern arising from calcium, magnesium and phosphate imbalances in the diet was noted and 
the Committee endorsed the JECFA estimate of an MTDI of 70 mg/kg bodyweight, calculated as P, for 
the sum of phosphates naturally present in food and derived from additives in diets nutritionally 
adequate in calcium. Provided this requirement was met a group ADI 'not specified' was allocated to 
the phosphates. 
The Committee also considered the optimum phosphorus content of infant formulae in its Report on 
Infant Formulae (2). A maximum limit for phosphorus of 22mg/100kJ in infant formulae was 
recommended in addition to a calcium/phosphorus ratio between 1.2 and 2. These recommendations 
are now incorporated into the European Commission Directive on Infant Formulae and Follow-on 
Formulae (5). Since infant formulae containing phosphoric acid as an additive will have to comply 
with these limits, the Committee considers that the use of phosphoric acid in infant formulae is 
acceptable. 
Thickening agents/stabilisers 
E407 Carrageenan 
E410 Carob bean gum 
E412 Guar gum 
E440 Pectins 
E1412 Distarch phosphate 
E1414 Acetylated distarch phosphate 
E1422 Acetylated distarch adipate 
The remaining new additives requested for use in infant formulae are all stabilisers used to keep 
liquid ready-to-feed formulae in a homogenous condition. Liquid ready-to-feed infant formulae are 
convenient and hygienic and have the advantage that it is easier to incorporate long chain 
polyunsaturated fatty acids, such as linoleic and alpha-linolenic acid, into the formula. 
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The Committee in its Report on Infant Formulae (2) did not recommend the use of thickening agents 
other than pre-cooked or gelatinised starch. This view was based in part on the recommendations 
published in 1977 by the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN) 
(6). 
The Committee notes that thickening agents have been extensively tested in animals in order to be 
permitted for general food use. Data on effects in young animals can be derived from reproduction or 
multigeneration studies where exposure of the offspring to thickening agents continues through 
lactation and weaning. The Committee considers that a lack of toxicological data on thickening 
agents is not a general problem but could apply in certain cases. 
On the other hand, in accordance with the general principles formulated above the Committee 
wishes to have more information about the technological function of each of these additives before it 
can be convinced that each new thickening agent/stabiliser requested is essential in liquid ready-to-
feed formulae. In addition to this general requirement the Committee has specific concerns about the 
use of the following thickening agents. 
E407 Carrageenan 
The general food use of carrageenan is currently under réévaluation by the Committee. During this 
review, the Committee noted the uptake of small amounts of carrageenan in certain species (7-10), the 
effects on the immune system in animals (11-14) and the increased intestinal permeability found in 
very young infants (15). Although there is no direct evidence of harm from carrageenan in human 
infants and no toxicologically significant effects were seen in infant baboons fed carrageenan in 
commercial infant formulae for 16 weeks (16), high levels of reassurance are needed to permit 
additives in infant formulae. The Committee could not exclude the possibility of absorption of 
carrageenan by the immature gut or the possibility that the absorbed material might affect the 
immune system in the infant. The Committee does not therefore consider carrageenan acceptable for 
use in infant formulae. 
E412 Guar gum 
The Committee notes the lack of a multigeneration study or a reproduction study in which exposure to 
guar gum continued through lactation and weaning. 
E1412 Distarch phosphate/EUU Acetylated distarch phosphate/E1422 Acetylated distarch 
adipate 
Pancreatic alpha-amylase activity is virtually zero at birth but several studies have demonstrated 
that neonates and young infants can digest a certain amount of starch (17,18). Indeed, in the absence of 
pancreatic amylase, salivary amylase and mucosal glucoamylase are thought to be sufficient to 
digest long-chain glucose polymers in many 1 month old infants (19). Salivary amylase activity in 
infants has been shown to be low at birth but, although variable, to increase rapidly to two-thirds of 
adult values by 3 months (20). 
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The amount of glucoamylase in the intestinal mucosa of infants under 6 months has been shown to be 
similar to that in older children (21) and it has been shown that digestion of starch is as rapid as in 
adults by 1 year of age (25). It is for these reasons that the Committee considers that pre-cooked or 
gelatinized starch can be added to infant formulae up to a concentration of 2g/100ml (2%) but not 
exceeding 30% of the total carbohydrate content (2). These recommendations are now incorporated 
into the European Commission Directive on Infant Formulae and Follow-on Formulae (5). 
The Committee notes that most enzymatic hydrolysis studies have demonstrated little or no 
difference between the digestibility of chemically modified and native starches and that greater 
differences were seen between different native starches (22). The in vitro hydrolysis studies relevant 
to the modified starches under consideration (22) used pancreatin (a pancreatic extract including 
alpha-amylase) and the in vivo hydrolysis studies used animals after weaning (22,23). These studies 
may not be relevant to infants where pancreatic amylase is low although salivary amylase has a 
similar spectrum of activity to pancreatic amylase (20). The Committee would prefer to see direct 
evidence indicating that infants can tolerate the levels of modified starches requested (2.5%) since it 
is concerned about the possibility of fermentive diarrhoea and/or modification of intestinal flora in 
very young infants fed formulae containing modified starches. The Committee also wishes to see 
detailed justification for the use of modified starches rather than pre-cooked or gelatinised starch 
where there is direct evidence that they can be tolerated in infants (17,18). 
The modified starches listed above were considered by the Committee for general food use in 1981 
(24). They were considered acceptable but, because they also contributed to the energy balance of the 
diet, no individual ADIs were set. In the same report, the Committee recommended that these (and 
most other modified starches) could be used in infant foods and foods for young children subject to a 
limit of 5%. The Committee wishes to make clear that this recommendation does not apply to infant 
formulae. The Committee considered the use of several modified starches in its Report on Weaning 
Foods (3) and concluded that this use was acceptable up to a combined limit of 5g/100g. 
Packaging gases - nitrogen and carbon dioxide 
The Committee considered the use of these compounds as acceptable for use as packaging gases for 
general food use in 1990 (4). The establishment of an ADI was not considered necessary. The 
Committee considers the use of these packaging gases acceptable for infant formulae. 
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SUMMARY TABLE OF ADDITIVES REQUESTED FOR USE IN INFANT FORMULAE 
ADDITIVE 
E338 Phosphoric acid 
E407 Carrageenan 
E410 Carib bean gum (locust 
bean gum) 
E412 Guar gum 
E440 Pectins 
E1412 Distarch phosphate 
(max S02 lOppm) 
E1414 Acetylated distarch 
phosphate (max S02 
lOppm) 
E1422 Acetylated distarch 
adipate (max S02 lOppm) 
Packaging gases - Nitrogen, 
Carbon dioxide 
MAX USE LEVEL 
READY TO EAT 
q.s. 
(0.3 g/1) 
1.0g/l alone or 
together 
1.0g/l alone or 
together 
1.0g/l alone or 
together 
25g/l alone or 
together 
25g/l alone or 
together 
25g/l alone or 
together 
q.s. 
PRODUCT 
Infant formula 
Liquid ready to eat 
infant formula 
Infant formula 
OPINION 
Acceptable if phosphorus 
<22mg/100kjand 
calcium/phosphorus ratio 1.2-2.0 
Not acceptable 
Await confirmation of essential need 
Await confirmation of essential need. 
No multigeneration study. 
Await confirmation of essential need 
Await confirmation of essential need; 
evidence that each is tolerated by 
infants at levels requested is 
desirable 
Await confirmation of essential need; 
evidence that each is tolerated by 
infants at levels requested is 
desirable 
Await confirmation of essential need; 
evidence that each is tolerated by 
infants at levels requested is 
desirable 
Acceptable 
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3.3 Additives for use in follow-on formulae 
E338 Phosphoric acid 
The Committee's evaluation of phosphoric acid for general food use is described above. The 
Committee's report on composition of follow-on formulae (2) states that mineral levels should be 
similar to those in cows milk and again the calcium/phosphorus ratio should not exceed 2. These 
recommendations are now incorporated into the European Commission Directive on Infant Formulae 
and Follow-on Formulae (5). Since follow-on formulae containing phosphoric acid as an additive will 
have to comply with these limits, the Committee considers that the use of phosphoric acid in follow-
on formulae is acceptable. 
E440 Pectins 
In its First Report on Emulsifiers and Stabilizers, the Committee endorsed the JECFA ADI 'not 
specified' for pectins (26). More recently (27), JECFA have considered further data on pectins 
including a three-generation reproduction study using 2% or 5% non-amidated pectin but no controls. 
There were no clear adverse toxicological effects. Pectin, at up to 1% in all weaning foods or up to 2% 
in gluten free weaning foods, was considered acceptable in the Committee's Report on Weaning Foods 
(3). The Committee considers the use of pectins in acidified follow-on formulae acceptable at the 
requested level of 5g/l (0.5%). 
Packaging gases - nitrogen and carbon dioxide 
The Committee considers the use of these packaging gases acceptable for follow-on formulae as well 
as infant formulae (section 3.2). 
SUMMARY TABLE OF ADDITIVES REQUESTED FOR USE IN FOLLOW—ON FORMULAE 
ADDITIVE 
Packaging gases - Nitrogen, 
Carbon dioxide 
E338 Phosphoric acid 
E440 Pectins 
MAX USE LEVEL 
READY TO EAT 
q.s. 
q.s. 
5.0 g/1 
PRODUCT 
Follow-on formula 
Follow-on formula 
Acidified follow-on 
formula 
OPINION 
Acceptable 
Acceptable if phophorus level similar 
to cow's milk and 
calcium/phosphorus ratio < 2.0 
Acceptable 
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3.4 Additives for use in weaning foods 
E407 Carrageenan 
The Committee's concerns about the use of carrageenan in very young infants are described above. By 
the age of 4-6 months the infants' gut is more fully developed but nevertheless the Committee is not 
completely satisfied that its use in weaning foods is acceptable. A decision on this point is deferred 
until the Committee has completed its re-evaluation of the general food use of Carrageenan. At that 
time the Committee will also decide whether there is any need to revise its previous opinion on the 
acceptability of Carrageenan in follow-on formulae (2). 
E354 L(+) Calcium tartrate 
The Committee endorsed the JECFA group ADI for tartrates of 30 mg/kg bodyweight in its Report on a 
First Series of Food Additives of Various Technological Functions (4). The JECFA evaluation did not 
report any multigeneration studies but tartrates are normal constituents of foods. The Committee's 
Report on Weaning Foods (3) lists L(+)-tartaric acid, sodium L(+)-tartrate and potassium L(+)-
tartrate as acceptable in weaning foods. The Committee considers that calcium L(+)tartrate is also 
acceptable in weaning foods. 
E472e Mono- and diacetyl-tartaric esters of mono and di- glycerides of fatty acids (DATEM) 
DATEM was considered to be acceptable by the Committee in 1977 (26) and the JECFA ADI of 50 
mg/kg bodyweight was endorsed. JECFA acknowledged (28) that some absorption of unhydrolysed 
compound could occur and based the ADI on a long term study published in 1950. The Committee is 
aware of some in vitro and in vivo hydrolysis studies on DATEM (29) which have been reported (30) 
to show that hydrolysis was incomplete. The Committee wishes to see this data before accepting this 
additive for use in weaning foods. 
E466 Carboxymethylcellulose 
The Committee has recently allocated an ADI not specified to a group of modified celluloses including 
E466. No multigeneration studies were included in the data package. The Committee wishes to 
complete its work on persorption of macromolecular food additives (see 1.2 (ii) above) before coming to 
a final view. Otherwise, the toxicological data does not indicate any effect likely to be of concern for 
infants and young children over weaning age. 
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SUMMARY TABLE OF ADDITIVES REQUESTED FOR USE IN 
ADDITIVE 
E407 Carrageenan 
E354 L(+) Calcium tartrate 
E472e Mono- and diacetyl 
tartaric esters of mono- and 
di-glycerides of fatty acids 
(DATEM) 
E466 
Carboxymethylcellulose 
MAX USE LEVEL 
READY TO EAT 
500 mg/kg 
Residue from 
raising agents 
5g/kg 
5g/kg 
10g/kg 
PRODUCT 
Desserts and 
puddings 
Substitute for 
sodium containing 
agents 
Gluten-free bakery 
products 
Toddler meals, 
chocolate flavour 
milks 
WEANING FOODS 
OPINION 
Decision deferred until completion 
of general review 
Acceptable 
Await further hydrolysis data 
Await view expert group on 
persorption of macromolecular 
additives 
3.5 Additives for use in nutrient preparations 
Industry have requested new or amended uses of various additives in nutrient preparations intended 
for addition to foods specially prepared for infants and young children. In accordance with the 
general principles outlined in the opening section of this opinion, the Committee needs more 
information about the functions of and justification for the use of these additives before coming to a 
final conclusion. It also requires quantitative estimates of the levels of carry-over into the final food 
if these additives are used at the concentrations requested. 
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OPINION EXPRESSED ON 11 DECEMBER 1992 
1. Terms of reference 
The Committee last considered carrageenan in its 7th Series Report in 1978 when it endorsed the 
acceptable daily intake of 0 - 75 mg/kg bw previously established by JECFA. The Committee was 
asked to re-evaluate Carrageenan in the light of more recent data. 
2. Discussion 
The Committee notes that since the re-evaluation of carrageenan by JECFA in 1984 new elements, 
complementary to the then available data base and thus essential for the present reassessment by the 
SCF, have become available. These relate in the first instance to new information on the influence of 
processing technology on the degradation of carrageenan in food, from the FDA, when processed at a 
pH similar to that found in the human stomach. Secondly, a discussion of the study by Ekström on the 
hydrolysis of carrageenan by artificial gastric juice highlighted the need for further experimental 
evidence on the possible protective effect of the gel form of carrageenan, under these conditions. 
Thirdly, information was supplied to the Committee that research was in progress, both on behalf of 
MAFF in the UK and the FDA in the USA, to clarify the effect of food processing on the molecular 
weight distribution of carrageenan in the food matrix. Fourthly, the original data of the long-term 
monkey study on carrageenan have only very recently become available for study by national 
authorities and the SCF. Finally, in-vitro models are now available to investigate the effects of 
carrageenan and of partially degraded carrageenan on the functional capacities of the immune 
system. 
3. Conclusion 
The Committee concluded, that it would be premature to arrive at a final conclusion on the proposals 
to adjust the present ADI until the results of the relevant studies now under way are available, 
particularly as there appears to be no immediate urgency in the present situation of use. 
The Committee also recommends that the use of carrageenan should not be permitted in infant 
formulas which would constitute almost the entire food supply for the infant at that age period. 
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I. ALGINATES 
(opinion expressed on 19th October 1990) 
The Committee previously evaluated alginic acid, its salts and its propylene glycol ester in 1978 (5th 
series of reports) when it endorsed the then current ADl's allocated by JECFA of 50 mg/kg b.w. for 
alginic acid and its salts (group ADI) and 25 mg/kg b.w. for propylene glycol alginate. 
On the basis of newly presented data together with existing data the Committee has now allocated 
an ADI "not specified" for alginic acid and its sodium, potassium and calcium salts. It stressed that 
the evaluation only covered the substances when used as food additives according to GMP and not 
special dietary or medical uses. 
For propylenglycol alginate an ADI of 25 mg/kg b.w. expressed as propylenglycol was allocated. The 
committee expressed the wish to re-evaluate the ADI of propylenglycol at a future stage and 
reiterated the request, as expressed in the 11th report series, that the intake from all sources of this 
solvent should be reviewed in relation to the ADI. 
II. MODIFIED STARCHES - STARCH SODIUM OCTENYL SUCCINATE 
(opinion expressed on 19th October 1990) 
The Committee has previously considered a number of chemically modified starches (Reports of the 
Scientific Committee for Food, 2nd Series 1976 and 13th Series - EUR 7982, 1982). It has categorised 
them into three groups, designated A, Β and C, according to their toxicological acceptability. 
Starches falling into Group A are considered acceptable for use in food without specific restrictions; 
those in Group Β are considered acceptable for use in foods in general but with restrictions on their use 
in infant foods; and those remaining in Group C after the review of 1982 (those modified by the use of 
epichlorhydrin) are considered not acceptable for use in foods. 
The Committee was asked to evaluate an additional modified starch, starch sodium octenyl 
succinate. The extent of the data available on this modified starch includes the results of short-term, 
90-day and long-term feeding studies in rats. Data on caloric utilisation in rats and from mutagenicity 
studies and in vitro enzyme digestibility studies are also available. The Committee found this 
product acceptable for use in food and placed it with the other previously evaluated modified 
starches in Group B, that is starches which are acceptable for use in foods in general without specific 
restrictions but which should be subject to a maximum limit of 5 % in foods specially prepared for 
infants and young children. 
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HI. EXTRACTION SOLVENTS - DICHLOROMETHANE 
(opinion expressed on 10th April 1992) 
In its opinion of 21 June 1991 concerning extraction solvents (Reports of the Scientific Committee for 
Food, 29th Series EUR 14482, 1992), the Committee found the use of dichloromethane acceptable for 
the limited use of the decaffeination of tea and coffee providing that levels in the beverage as 
consumed are subject to a limit of not more than 50 μg/litre. The Committee was subsequently informed 
that this solvent is also presently used as an extraction solvent in the production of flavourings, 
notably those prepared from certain herbs and spices, and was asked to consider the acceptability of 
its continued use for this purpose. 
The Committee was provided with information indicating that residues of dichloromethane in those 
foods where the flavourings concerned are used, do not exceed 20 μg/kg and are in practice usually less 
than 1.25 μ/kg. It concluded that the additional exposure which would result from these uses is small 
and that, taken together, the residues resulting from the decaffeination of tea and coffee and from 
current uses as an extractant for flavourings constitute no hazard to health. The Committee agrees 
that the use of dichloromethane for both of these purposes is acceptable. 
IV. GLYCEROL ESTERS OF WOOD ROSIN 
(opinion expressed on 19th June 1992) 
Glycerol esters of wood rosin were previously evaluated by the Committee in 1990 (26th series of 
reports, EUR 13913) when a temporary ADI of 0,5 mg/kg b.w. was allocated pending the results of a 
new 90-day rat study using well specified commercial product. 
The results of a recent 90-day rat study have now been provided to the Committee and indicate a 
NOEL of 2500 mg/kg b.w. Assurances have been given that the material tested was the same as that 
used in previous studies. Although the study was not of long-term duration, when taken together with 
the previous studies it was adequate for the purpose of establishing a full ADI. Taking into account 
the 90 day duration, the Committee applied a safety factor of 200 and allocated to glycerol esters of 
wood rosin a full ADI of 12.5 mg/kg b.w. 
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V. FOOD IRRADIATION: USE IN RELATION TO CAMEMBERT 
(opinion expressed on 19th June 1992) 
The Committee has previously expressed it views on the irradiation of food in its 18th series of 
reports (EUR 10840, 1989). The Committee was asked to consider whether Camembert cheese could be 
added to the food classes listed in that report for which irradiation was considered acceptable. It 
was informed that the use of gamma-irradiation at doses up to 2.5 kGy had been requested as a means 
of controlling the micro-flora of Camembert cheese manufactured from raw milk 
The information provided in support of the request indicated that the efficacy of 2.5 kGy gamma-
radiation as a control for Lysteria had been adequately demonstrated, that there were no indications 
of the induction of radio-resistant strains of micro-organisms, and that such depletion of nutrients 
(vitamins) as occurred could not be considered significant because Camembert cheese was not a 
significant dietary source of the vitamins concerned. The Committee noted that the dossier included 
the results of taste panel evaluations of treated cheeses of an appropriate age and reported the 
absence of organoleptic effects. 
The Committee agreed that the treatment of Camembert cheeses manufactured from raw milk with 
gamma-radiation at doses up to 2.5 kGy was acceptable from a health point of view. 
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